Kontafarma China Holdings Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was HKD 430.71 million compared to HKD 451.09 million a year ago. Net income was HKD 39.14 million compared to net loss of HKD 31.18 million a year ago.

Basic earnings per share from continuing operations was HKD 0.007 compared to basic loss per share from continuing operations of HKD 0.0092 a year ago. Basic earnings per share was HKD 0.007 compared to basic loss per share of HKD 0.0056 a year ago.